MARK SHEPTOFF FINANCIAL PLANNING, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARK SHEPTOFF FINANCIAL PLANNING, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2018$510,000
+40.1%
4,800
-21.3%
0.35%
+49.4%
Q4 2017$364,000
+149.3%
6,1000.0%0.24%
+141.8%
Q3 2017$146,000
+121.2%
6,100
+79.4%
0.10%
+117.8%
Q2 2017$66,000
+247.4%
3,400
+324.5%
0.04%
+221.4%
Q1 2017$19,000
-50.0%
801
-74.2%
0.01%
-50.0%
Q4 2016$38,000
+5.6%
3,100
+47.6%
0.03%
+3.7%
Q3 2016$36,0002,1000.03%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders